Inducible nitric oxide synthase expression in N-nitrosomethylbenzylamine (NMBA)-induced rat esophageal tumorigenesis

Molecular Carcinogenesis

Volumn 40, Issue 4, 2004, Pages 232-240

  Chen, Tong ^a   Stoner, Gary D ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Chemical carcinogenesis; Esophagus; Nitric oxide synthase; Nitrosamine; Rodent

Indexed keywords

ARGININE; INDUCIBLE NITRIC OXIDE SYNTHASE; N BENZYL N METHYLNITROSAMINE; NITRIC OXIDE; PEROXYNITRITE; SUPEROXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL GROWTH; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; CYTOTOXICITY; DNA DAMAGE; ENZYME ISOLATION; EPITHELIUM CELL; ESOPHAGUS CANCER; ESOPHAGUS MUCOSA; ESOPHAGUS TUMOR; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; NONHUMAN; PAPILLOMA; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

ANIMALS; CARCINOGENS; CELL TRANSFORMATION, NEOPLASTIC; DIMETHYLNITROSAMINE; EPITHELIUM; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; IMMUNOHISTOCHEMISTRY; MALE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

ANIMALIA; RODENTIA;

EID: 4043165470     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/mc.20035     Document Type: Article

References (53)

1. Blot WJ, McLaughlin JK. The changing epidemiology of esophageal cancer. Semin Oncol 1999;26:2.
2. American Cancer Society. Cancer facts and figures. Atlanta, GA: American Cancer Society, 2004.
3. Fu S, Ramanujam KS, Wong A, Fantry GT. Increased expression and cellular localization of iNOS and COX-2 in Helicobacter pylori gastritis. Gastroenterology 1999;116: 1319-1329.
4. Dijkstra G, Moshage H, van Dullemen HM, et al. Expression of nitric oxide synthase and formation of nitrotyrosine and reactive oxygen species in inflammatory bowel disease. J Pathol 1998;186:416-421.
5. Jadeski LC, Hum KO, Chakraborty C, Lala PK. Nitric oxide promotes murine mammary tumour growth and metastasis by stimulating tumour cell migration, invasiveness and angiogenesis. Int J Cancer 2000;86:30-39.
6. Andrew PJ, Harant H, Lindley IJ. Nitric oxide regulates IL-8 expression in melanoma cells at the transcriptional level. Biochem Biophys Res Commun 1995;214:949-956.
7. Jenkins DC, Charles IG, Baylis SA, Lelchuk R, Radomski MW, Moncada S. Human colon cancer cell lines show a diverse pattern of nitric oxide synthase gene expression and nitric oxide generation. Br J Cancer 1994;70:847-849.
8. Tanaka H, Kijima H, Tokunaga T, et al. Frequent expression of inducible nitric oxide synthase in esophageal squamous cell carcinomas. Int J Oncol 1999;14:1069-1073.
9. Wilson KT, Fu S, Ramanujam KS, Meltzer SJ. Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas. Cancer Res 1998;58:2929-2934.
10. Reveneau S, Arnould L, Jolimoy G, et al. Nitric oxide synthase in human breast cancer is associated with tumor grade, proliferation rate, and expression of progesterone receptors. Lab Invest 1999;79:1215-1225.
11. Gallo O, Masini E, Morbidelli L, et al. Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer. J Natl Cancer Inst (Bethesda) 1998;90:587-596.
12. Liu CY, Wang CH, Chen TC, Lin HC, Yu CT, Kuo HP. Increased level of exhaled nitric oxide and up-regulation of nitric oxide synthase in patients with primary lung cancer. Br J Cancer 1998;78:534-541.
13. Ambs S, Bennett WP, Merriam WG, et al. Relationship between p53 mutations and inducible nitric oxide synthase expression in human colorectal cancer. J Natl Cancer Inst (Bethesda) 1999;91:86-88.
14. Hamaoka R, Yaginuma Y, Takahashi T, et al. Different expression patterns of nitric oxide synthase isozymes in various gynecological cancers. J Cancer Res Clin Oncol 1999; 125:321-326.
15. Nathan C, Xie QW. Nitric oxide synthases: Roles, tolls, and controls. Cell 1994;78:915-918.
16. Tamir S, Tannenbaum SR. The role of nitric oxide (NO) in the carcinogenic process. Biochim Biophys Acta 1996;1288: F31-F36.
17. 2 promoter. Proc Natl Acad Sci USA 1996;93:1054-1059.
18. Salkowski CA, Detore G, McNally R, van Rooijen N, Vogel SN. Regulation of inducible nitric oxide synthase messenger RNA expression and nitric oxide production by lipopolysaccharide in vivo: The roles of macrophages, endogenous IFN-$, and TNF receptor-1-mediated signaling. J Immunol 1997;158: 905-912.
19. Cox GW, Melillo G, Chattopadhyay U, Mullet D, Fertel RH, Varesio L. Tumor necrosis factor-dependent production of reactive nitrogen intermediates mediates IFN- plus IL-2-induced murine macrophage tumoricidal activity. J Immunol 1992;149:3290-3296.
20. Michel T, Feron O. Perspective series: Nitric oxide and nitric oxide synthases. J Clin Invest 1997;100:2146-2152.
21. Marletta MA. Nitric oxide synthase: Aspects concerning structure and catalysis. Cell 1994;78:927-930.
22. Wink DA, Kasprzak KS, Maragos CM, et al. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science 1991;254:1001-1003.
23. Nguyen T, Brunson D, Crespi CL, Penman BW, Wishnok JS, Tannenbaum SR. DNA damage and mutation in human cells exposed to nitric oxide. Proc Natl Acad Sci USA 1992;89: 3030-3034.
24. Merchant K, Chen H, Gonzalez TC, Keefer LK, Shaw BR. Deamination of single-stranded DNA cytosine residues in aerobic nitric oxide solution at micromolar total NO exposures. Chem Res Toxicol 1996;9:891-896.
25. Graziewicz M, Wink DA, Laval F. Nitric oxide inhibits DNA ligase activity. Potential mechanisms for NO mediated DNA damage. Carcinogenesis 1996;17:2501-2505.
26. Ischiropoulos H, al-Mehdi AB. Peroxynitrite-mediated oxidative protein modifications. FEBS Lett 1995;364:279-282.
27. Beckman JS. Oxidative damage and tyrosine nitration from peroxynitrite. Chem Res Toxicol 1996;9:836-844.
28. Marletta MA, Yoon PS, Iyengar R, Leaf CD, Wishnok JS. Macrophage oxidation of L-arginine to nitrite and nitrate: Nitric oxide is an intermediate. Biochemistry 1988;27:8706-8711.
29. Lu SH. Relevance of nitrosamines to esophageal cancer in China. IARC Sci Publ 1991;105:11-17.
30. Pruessmann R, Stewart BW. N-nitroso carcinogens. In: Searle CE, editor. Chemical carcinogenesis. Washington D.C.: American Chemical Society Monograph; 1984. pp 643-828.
31. Liston BW, Gupta A, Nines R, et al. Incidence and effects of Ha-ras codon 12 G → A transition mutations in preneoplastic lesions induced by N-nitrosomethylbenzylamine in the rat esophagus. Mol Carcinog 2001;32:1-8.
32. Knowles RG, Moncada S. Nitric oxide synthases in mammals. Biochem J 1994;298:249-258.
33. Billiar TR. Nitric oxide: Novel biology with clinical relevance. Ann Surg 1995;221:339-349.
34. Goldstein SR, Yang G, Chen X, Curtis SK, Yang CS. Studies of iron deposits, inducible nitric oxide synthase and nitrotyrosine in a rat model for esophageal adenocarcinoma. Carcinogenesis 1998;19:1445-1449.
35. Brennan PA, Palacios-Callender M, Sinclair D, Spedding AV, Zaki GA. Does expression of inducible nitric oxide synthase correlated with severity of oral epithelial dysplasia? J Craniomaxillofac Surg 2000;28:44-48.
36. Chhatwal VJ, Ngoi SS, Chan ST, Chia YW, Moochhala SM. Aberrant expression of nitric oxide synthase in human polyps, neoplastic colonic mucosa, and surrounding peritumoral normal mucosa. Carcinogenesis 1994;15:2081-2085.
37. Klotz T, Bloch W, Volberg C, Engelmann U, Addicks K. Selective expression of iNOS in human prostate carcinoma. Cancer (Philadelphia) 1998;82:1897-1903.
38. Lowenstein CJ, Alley EW, Raval P, et al. Macrophage nitric oxide synthase gene: Two upstream regions mediate induction by interferon and lipopolysaccharide. Proc Natl Acad Sci USA 1993;90:9730-9734.
39. Murali K, Rao K. Molecular mechanisms regulating iNOS expression in various cell types. J Toxicol Environ Health 2000;3:27-58.
40. Huang C, Huang Y, Li J, et al. Inhibition of benzo(a)pyrene diol-epoxide-induced transactivation of activated protein 1 and nuclear factor-κB by black raspberry extracts. Cancer Res 2002;62:6857-6863.
41. Dong WK, Sovak MA, Zanieski G, et al. Activation of NF-κB/Rel occurs early during neoplastic transformation of mammary cells. Carcinogenesis 2000;21:871-879.
42. Stoner GD, Gupta A. Etiology and chemoprevention of esophageal squamous cell carcinoma. Carcinogenesis 2001; 22:1737-1746.
43. Wang Y, You M, Reynolds SH, et al. Mutational activation of the cellular Harvey ras oncogene in rat esophageal papillomas induced by methylbenzylnitrosamine. Cancer Res 1990; 50:1591-1595.
44. Wang D, Weghorst CM, Calvert RJ, Stoner GD. Mutations in the p53 tumor suppressor gene in rat esophageal papillomas induced by N- nitrosomethylbenzylamine. Carcinogenesis 1996;17:625-630.
45. Wang QS, Sabourin CLK, Bijur GN, Robertson FM, Stoner GD. Alterations in transforming growth factor-α and epidermal growth factor receptor expression during rat esophageal tumorigenesis. Mol Carcinog 1996;15:144-153.
46. Wang QS, Sabourin CLK, Wang H, Stoner GD. Overexpression of cyclin D1 and cyclin E in N-nitrosomethylbenzylamine-induced rat esophageal tumorigenesis. Carcinogenesis 1996; 17:1583-1588.
47. Carlton PS, Gopalakrishnan R, Gupta A, Stoner GD. Piroxicam is an ineffective inhibitor of N-nitrosomethylbenzylamine-induced tumorigenesis in the rat esophagus. Cancer Res 2002;62:4376-4382.
48. Khare L, Sabourin CLK, DeYoung BR, Wagner BA, Stoner GD. Alterations in the expression of α6β4 integrin and p21/WAF1/Cip1 in N-nitrosomethylbenzylamine-induced rat esophageal tumorigenesis. Mol Carcinog 1998;21:185-193.
49. Ambs S, Bennett WP, Merriam WG, et al. Relationship between p53 mutations and inducible nitric oxide synthase expression in human colorectal cancer. J Natl Cancer Inst (Bethesda) 1999;91:86-88.
50. Souici AC, Mirkovitch J, Hausel P, Keefer LK, Felley-Bosco E. Transition mutation in codon 248 of the p53 tumor suppressor gene induced by reactive oxygen species and a nitric oxide-releasing compound. Carcinogenesis 2000;21: 281-287.
51. DuBois RN, Abramson SB, Crofford L, et al. Cyclooxygenase in biology and disease. FASEB J 1998;12:1063-1073.
52. Salvemini D. Cyclooxygenase: An important transduction system for the multifaceted roles of nitric oxide. In: Sima AAF, editor. Pathophysiology and clinical applications of nitric oxide, part A. Amsterdam: Harwood Acad Publ; 1999. pp 155-170.
53. Weinberg JB. Nitric oxide synthase 2 and cyclooxygenase 2 interactions in inflammation. Immunol Res 2000;22: 319-341.